Vemurafenib, an inhibitor that induces apoptosis in cells expressing mutant (V600E) serine/threonine-protein kinase B-raf (BRAF), seen in > 50% of malignant melanomas (Fig. 3). This evidence concerns the gene BRAF and melanoma.